The Korean Journal of Hepatology 2010-03-01

[A case report of alverine-citrate-induced acute hepatitis].

Jee Young Han, Jin Woo Lee, Joon Mee Kim, Kowoon Joo, Ung Chon, Jung Il Lee, Seok Jeong, Don Haeng Lee, Young Soo Kim, Kyung Sun Min

Index: Korean J. Hepatol. 16(1) , 75-8, (2010)

Full Text: HTML

Abstract

Alverine citrate is one of the most commonly used antispasmodic drugs for patients with irritable bowel syndrome. Alverine-citrate-induced hepatotoxicity is extremely rare, with only a few cases having been reported worldwide. We present a case of a 75-year-old female patient who experienced complicated jaundice and abdominal discomfort after taking alverine citrate. Other causes of hepatitis were ruled out and the results of the liver function test returned to normal after ceasing the drug. This is the first case report in Korea of alverine-citrate-induced hepatotoxicity.

Related Compounds

Related Articles:

Validated LC-MS/MS method for determination of Alverine and one of its hydroxy metabolites in human plasma along with its application to a bioequivalence study.

2009-01-15

[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 877(3) , 197-206, (2009)]

A general practice study to compare alverine citrate with mebeverine hydrochloride in the treatment of irritable bowel syndrome.

1986-07-01

[Br. J. Clin. Pract. 40(7) , 276-8, (1986)]

Alverine citrate, simeticone, and Rome III irritable bowel syndrome.

2010-04-01

[Aliment. Pharmacol. Ther. 31(7) , 767-8; author reply 768-9, (2010)]

[Dynamics of clinical symptoms and indices of visceral sensitivity in patients with the irritated bowels syndrome treated with meteospasmyl].

2005-01-01

[Eksp. Klin. Gastroenterol. (1) , 25-9, (2005)]

Acute hepatitis caused by alverine associated with anti-lamin A and C autoantibodies.

1997-08-01

[J. Hepatol. 27(2) , 399-403, (1997)]

More Articles...